Literature DB >> 6803813

Discriminative value of lipids and apoproteins in coronary heart disease.

G De Backer, M Rosseneu, J P Deslypere.   

Abstract

Serum cholesterol, HDL cholesterol (HDL-C), and apoproteins, A1, A2 and B were determined in 70 male survivors of myocardial infarction and in an equal number of healthy controls, matched for age, sex and body mass index. In univariate analyses, the Apo B/Apo A1 ratio discriminated the best between cases and controls, giving a 72% exact classification. In a multivariate analysis, the Apo B/Apo A1 ratio, HDL-C and the Apo A2/Apo A1 ratio contributed independently to the discrimination of cases from controls while the overall exact classification was 82%. These promising results were comparable in younger and older subgroups. Thus, the determination of apoproteins yielded complementary information in this cross-sectional survey and warrants further study in a prospective setting.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803813     DOI: 10.1016/0021-9150(82)90150-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

1.  A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension.

Authors:  M Ligueros; R Unwin; M R Wilkins; J Humphreys; S J Coles; J Cleland
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

2.  High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects.

Authors:  P V Luoma; A Rautio; J Stengård; E A Sotaniemi; J Marniemi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Serum lipoproteins in day and shift workers: a prospective study.

Authors:  A Knutson; H Andersson; U Berglund
Journal:  Br J Ind Med       Date:  1990-02

4.  Genetic analysis of apolipoprotein A-I in two dietary environments.

Authors:  J Blangero; J W MacCluer; C M Kammerer; G E Mott; T D Dyer; H C McGill
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

5.  The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects.

Authors:  R I Press; J Geller; G W Evans
Journal:  West J Med       Date:  1990-01

6.  Apolipoprotein A and prognosis after myocardial infarction in non-diabetic men.

Authors:  H Pollak; O Arnoldner; W Enenkel; M Fischer; D Trubert-Exinger
Journal:  Klin Wochenschr       Date:  1991-01-04

7.  Predictors of mortality in very old subjects aged 80 years or over.

Authors:  E Casiglia; P Spolaore; G Ginocchio; G Colangeli; G Di Menza; M Marchioro; A Mazza; G B Ambrosio
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

8.  Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.

Authors:  B Teng; G R Thompson; A D Sniderman; T M Forte; R M Krauss; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Paraoxonase activity in human pericardial fluid: its relationship to coronary artery disease.

Authors:  A F Hernandez; A Pla; A Valenzuela; F Gil; H P Hougen; E Villanueva
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

10.  Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.

Authors:  A Kaptein; L Roodenburg; H M Princen
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.